The global immunodiagnostics market to grow at a CAGR of 7.80% during the period 2017-2021.
The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.
The latest trend gaining momentum in the market is automation and system integration. An increased number of consumers are opting for semi-automated and highly automated systems over conventional (manual) systems. Laboratory automation results in increased productivity and efficient handling of large test volumes with fewer people and is useful in the case of critical shortage of trained technicians.
According to the report, one of the major drivers for this market is technological advances. The incidence of autoimmune diseases is rising worldwide, thus increasing the volume of samples collected for analysis. This has led to a greater demand for automation for rapid analysis and interpretation of results from autoimmune disease diagnostics.
- Abbott Laboratories
- Roche Diagnostics
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by application
Part 08: Market segmentation by end-users
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/j9tmnp/global